Publications by authors named "Gemma Azaceta"

Claim this Profile
N
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells and , especially if combined with daratumumab.
David Giraldos, Evelyn Galano-Frutos, Laura Cambronero-Arregui, Manuel Beltrán Visiedo, Eduardo Romanos, Gemma Azaceta

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL.
Joaquín Marco-Brualla, Oscar Gonzalo, Gemma Azaceta, Isabel Izquierdo, Luis Palomera

Cells· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials.
Celia González-Gil, Thaysa Lopes, Mireia Morgades, Francisco Fuster-Tormo, Pau Montesinos, Gemma Azaceta

Hemasphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.
Lucía Pérez-Lamas, Adrián Segura Diaz, Regina García Delgado, Alberto Álvarez-Larrán, María Alicia Senin, Gemma Azaceta

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, Xavier Calvo, Felicitas Isabel Schulz, Gemma Azaceta

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulomatous dermatitis in the context of chronic myelomonocytic leukemia: More than just reactive infiltrates. An illustrative case report with literature review.
Mar García-García, Julia Jiménez Elbaile, Gemma Azaceta, Marta Lorda, Lucía Prieto-Torres

J Cutan Pathol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.
Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, Marta Cuenca, Andrea Benedi, Gemma Azaceta

Mol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.
Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta

Oncoimmunology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulomatous Dermatitis Heralding Myelodisplastic/Myeloproliferative Neoplasms. Neoplastic or Reactive Cells? A Study of 2 Cases.
Lucía Prieto-Torres, Carlos Santonja, Cristina Chamizo, Miguel F García-Gil, Victoria Lezcano, Gemma Azaceta

Am J Dermatopathol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma.
Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.
Chantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, Jessy Présumey, Javier Hernandez, Gemma Azaceta

Oncoimmunology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.
Tania Calvo, Chantal Reina-Ortiz, David Giraldos, María Gascón, Daniel Woods, Gemma Azaceta

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.
Diego Sánchez-Martínez, Pilar M Lanuza, Natalia Gómez, Aura Muntasell, Elisa Cisneros, Gemma Azaceta

Front Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
Meritxell Nomdedeu, Xavier Calvo, Arturo Pereira, Anna Carrió, Francesc Solé, Gemma Azaceta

Genes Chromosomes Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes.
Dolors Costa, Concha Muñoz, Ana Carrió, Amparo Arias, Cándida Gómez, Gemma Azaceta

Acta Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human NK cells activated by EBV lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.
Diego Sánchez-Martínez, Gemma Azaceta, Aura Muntasell, Nacho Aguiló, David Núñez

Oncoimmunology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
Joaquín Sánchez-García, Consuelo Del Cañizo, Ignacio Lorenzo, Benet Nomdedeu, Elisa Luño, Gemma Azaceta

Br J Haematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis.
Silvia M Rojas, María Díez-Campelo, Elisa Luño, Mónica Cabrero, Carme Pedro, Gemma Azaceta

Leuk Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors.
Adriana Aporta, Elena Catalán, Patricia Galán-Malo, Ariel Ramírez-Labrada, Marta Pérez, Gemma Azaceta

Biochem Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
Dolors Costa, Concha Muñoz, Ana Carrió, Meritxell Nomdedeu, Xavier Calvo, Gemma Azaceta

Genes Chromosomes Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production.
Laura Vela, María Contel, Luis Palomera, Gemma Azaceta, Isabel Marzo

J Inorg Biochem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.
Gemma Azaceta, Maria J Calasanz, Victoria Dourdil, Elena Bonafonte, Isabel Izquierdo

Leuk Lymphoma· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
Luis Palomera, José Ma Domingo, Carlos Sola, Gemma Azaceta, María Teresa Calvo

Haematologica· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis